gracecast-140_lung_highlights in lung cancer, 2012: new options for egfr mutation-positive nsclc
Published 11 years ago • 253 plays • Length 18:51Download video MP4
Download video MP3
Similar videos
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
10:37
gracecast-141_lung_highlights in lung cancer, 2012: alk inhibitors for patients with alk or ros1
-
9:18
gracecast - treatment options for metastatic nsclc
-
20:34
gracecast-118_lung-cancer_asco 2012 lung cancer highlights: question and answer session
-
5:27
gracecast-144_lung_highlights in lung cancer, 2013: mek inhibitors for kras mutation-positive nsclc
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
-
5:13
gracecast-115_lung-cancer_asco 2012 lc highlights: dr. neal on lux-lung 3 trial for advanced nsclc
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
6:31
gracecast - lcvl - what is the best first line treatment for patients with advanced egfr mutation-po
-
6:00
perioperative keytruda for early stage nsclc-leading developments & current questions in lung cancer
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
2:08
grace targeted therapies lung cancer 2021 - approved therapy for a cdkn2a secondary mutation?
-
7:37
rare fusions in nsclc: ret - targeted therapies in lung cancer 2023
-
5:59
gracecast - are there treatment options for patients with her-2 nsclc
-
3:21
q&a: treatment options for patients with leptomeningeal disease - targeted therapies in lung cancer
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc